Prothena Corp. plc Stock
Price
Target price
€19.40
€19.40
1.040%
-
1.040%
€78.70
23.08.24 / Tradegate
WKN: A1KAVV / Symbol: PRTA / Name: Prothena Corp / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Prothena Corp. plc Stock
Prothena Corp. plc gained 1.040% today.
Prothena Corp. plc is currently one of the favorites of our community with 13 Buy predictions and no Sell predictions.
Based on the current price of 19.4 € the target price of 78 € shows a potential of 302.06% for Prothena Corp. plc which would more than double the current price.
Pros and Cons of Prothena Corp. plc in the next few years
Pros
?
M***** P*******
?
B****
?
S********** s********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prothena Corp. plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prothena Corp. plc | 1.040% | 7.778% | -13.393% | -63.048% | -44.253% | -63.396% | 142.500% |
| Evolus Inc | 2.940% | 16.667% | 21.739% | 64.706% | 54.696% | 51.351% | - |
| Ardelyx Inc. | 5.770% | 6.941% | 7.836% | 67.751% | -1.903% | 364.754% | 79.034% |
| Coherus Bioscien. | 4.560% | 8.696% | -18.879% | -71.053% | -59.293% | -90.553% | -93.737% |
Comments
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $66.00 to $62.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at HC Wainwright from $90.00 to $84.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
